Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates
Harmony Biosciences Holdings, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $31.59
+3.8% in 7d after detection
Post-detection moves
1h
—
1d
+3.1%
3d
-1.0%
7d
+3.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS